Maxalt and Thinking abnormal - a phase IV clinical study of FDA data

Summary:

Thinking abnormal is reported as a side effect among people who take Maxalt (rizatriptan benzoate), especially for people who are female, 60+ old, also take Ativan, and have Eye inflammation.

The phase IV clinical study analyzes which people have Thinking abnormal when taking Maxalt. It is created by eHealthMe based on reports of 11,566 people who have side effects when taking Maxalt from the FDA, and is updated regularly.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,752 Maxalt users. Check the latest studies of Maxalt.

What is Thinking abnormal?

Thinking abnormal is found to be associated with 1,138 drugs and 1,176 conditions by eHealthMe. Check the latest studies of Thinking abnormal.

On Dec, 08, 2025

11,566 people reported to have side effects when taking Maxalt.
Among them, 21 people (0.18%) have Thinking abnormal.

Among these 21 people:

What is the gender of people who have Thinking abnormal when taking Maxalt? *

female: 84.21 %
male: 15.79 %

What is the age of people who have Thinking abnormal when taking Maxalt? *

What are other drugs people take besides Maxalt? *

What are other side effects people have besides Thinking abnormal? *

Stress And Anxiety: 7 people, 33.33%
Confusional State: 7 people, 33.33%
Insomnia (sleeplessness): 7 people, 33.33%
Memory Loss: 5 people, 23.81%
Feeling Abnormal: 5 people, 23.81%
Speech Disorder: 4 people, 19.05%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 4 people, 19.05%
Nausea (feeling of having an urge to vomit): 4 people, 19.05%
Abulia (lack of will or initiative): 4 people, 19.05%
Dizziness: 3 people, 14.29%

What are the existing conditions these people have? *

Headache (pain in head): 4 people, 19.05%
Eye Inflammation: 4 people, 19.05%
Depression: 3 people, 14.29%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 14.29%
Stress And Anxiety: 3 people, 14.29%
Quit Smoking: 2 people, 9.52%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 4.76%
Back Pain: 1 person, 4.76%
Blood Iron Decreased: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxalt:

Maxalt (12,752 reports)

Browse all side effects of Maxalt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thinking abnormal:

Thinking abnormal (1,138 drugs)

Browse all the conditions that are associated with Thinking abnormal:

Thinking abnormal (1,176 conditions)

Drugs similar to Maxalt and Thinking abnormal :

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate (the active ingredients of Maxalt) and Maxalt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.